Oral GLP-1 drugs may quiet the brain’s food craving circuit
Popular weight-loss and diabetes medications such as semaglutide and Ozempic belong to a broader group known as GLP-1…
A new cholesterol pill could change the fight against heart disease
Last week, the Food and Drug Administration (FDA) approved a small pill called enlicitide. It is a tablet…
Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
(Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
Rethinking addiction in the age of Ozempic : TED Radio Hour : NPR
GLP-1s could be a breakthrough in addiction treatment. But is medicine alone enough to treat such a complicated…
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
The pharmaceutical company Merck said on Friday that it would license seven generic drugmakers to produce a low-cost…
GLP-1 drugs reshaping fitness: UAE experts stress strength training is key
For decades, the fitness industry revolved around one goal — helping people lose weight. Today, the growing popularity…
KVUE Stock Rises As FDA Approves Tylenol Combination Despite Trump Administration’s Pushback
The green light arrives in spite of continued pressure on the Tylenol brand. In September 2025, President Donald…
FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg)
FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.Addresses…
Raleigh-area patient hopeful of new FDA-approved cholesterol pill
RALEIGH, N.C. (WTVD) — For nearly two years, Steve Church has been working with doctors to keep his…
FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’
A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded,…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
Can Ozempic rewire the addicted brain? : NPR
Part 1 of the TED Radio Hour episode Rethinking addiction in the age of Ozempic GLP-1s revolutionized weight-loss and diabetes…